Skip to main content
Peptide Guide · Preclinical

Last updated: June 2026 · Reviewed June 2026 · Built by the InjectBuddy team

What is BPC-157? A plain-language guide

BPC-157 is a synthetic 15-amino-acid peptide derived from a protein found in human gastric juice, with all published evidence coming from preclinical animal and in-vitro studies — there is no FDA-approved human formulation and no clinically established dose. This guide explains what the molecule is, why it remains investigational, and the reconstitution arithmetic that converts a microgram figure into syringe units, answering the questions people ask most.

Key takeaways. BPC-157 is a research-only pentadecapeptide; evidence is animal-model, not human. Vials are labelled in mg, doses are discussed in mcg (1 mg = 1,000 mcg). Your draw depends entirely on how much bacteriostatic water you add. Want the numbers worked for you? Use the BPC-157 dose calculator.

What BPC-157 actually is

BPC-157 (Body Protection Compound-157) is a stable partial sequence of a protein found in human gastric juice. The "157" refers to the fragment; the synthetic version sold as a research chemical is a 15-residue peptide — a pentadecapeptide. It ships as a lyophilised (freeze-dried) white powder in sealed glass vials, most often 5 mg or 10 mg, and must be dissolved in bacteriostatic water before it could ever be drawn into a syringe. It is never supplied pre-mixed.

Most of the published interest comes from rodent studies of gastrointestinal, tendon, and wound-healing outcomes — for example, a review of its proposed cytoprotective and vascular-recruitment mechanisms in the gut, and a cell-and-tendon study showing accelerated tendon outgrowth in culture and in rats. These are mechanistic, animal, and in-vitro findings.

Why this stays a maths reference, not a dosing protocol

Here is the honest caveat that runs through this whole page: BPC-157 is preclinical. A 2019 review of its musculoskeletal effects states plainly that the consistently positive healing results reported so far come from animal models and that human clinical trials are lacking. No regulator has approved a human dose, so there is no "standard 250 mcg" the way there is a standard semaglutide titration. Any microgram figure you see online is a community convention, not a validated prescription.

What we can do without overstepping is the arithmetic. Reconstitution maths is identical for any peptide: it does not assert that a dose is safe or effective — it only tells you how many units a given amount of solution occupies. That distinction is the whole point of this guide, and it is why this page is a calculator companion rather than a treatment plan. For the broader chemistry of these molecules, see what a peptide is.

mg on the label, mcg in the conversation

The single biggest source of confusion is unit mismatch. Vials are labelled in milligrams; doses are discussed in micrograms. The conversion never changes: 1 mg = 1,000 mcg. So a 5 mg vial holds 5,000 mcg of peptide and a 10 mg vial holds 10,000 mcg. A commonly quoted 250 mcg figure is therefore one-twentieth of a 5 mg vial — the vial size alone tells you nothing about your draw until you also know how much water went in.

How this is calculated

Every reconstitution problem is two divisions and one multiplication:

  1. Concentration = total peptide (mcg) ÷ bacteriostatic water added (mL). This gives mcg per mL.
  2. Draw volume = your dose (mcg) ÷ concentration (mcg/mL). This gives mL.
  3. Syringe units = draw volume (mL) × 100, because a U-100 insulin syringe marks 100 units per mL.
Master example — 250 mcg from a 5 mg vial + 2 mL water

Concentration: 5,000 ÷ 2 = 2,500 mcg/mL

Draw: 250 ÷ 2,500 = 0.10 mL

= 10 units on a U-100 syringe

Common BPC-157 doses to syringe units

The table below maps microgram figures discussed in the research-chemical community to draw volumes and U-100 units, all assuming a 5 mg vial reconstituted with 2 mL of BAC water (2,500 mcg/mL). These are unit conversions, not recommendations.

Dose (mcg)Fraction of 5 mg vialDraw volume (mL)U-100 units
100 mcg2%0.04 mL4 units
200 mcg4%0.08 mL8 units
250 mcg5%0.10 mL10 units
300 mcg6%0.12 mL12 units
500 mcg10%0.20 mL20 units
750 mcg15%0.30 mL30 units

Notice the pattern: at this concentration, every 25 mcg equals exactly 1 unit. Re-water the vial differently and the whole column shifts — which is why the diagram below shows how concentration controls the draw.

BPC-157 dose to syringe units by BAC water volume Three concentration bars showing how a fixed 250 mcg BPC-157 dose needs more syringe units as more bacteriostatic water is added to the same 5 mg vial. Same 250 mcg dose, 5 mg vial — units depend on water added 1 mL → 5,000 mcg/mL 5 units 2 mL → 2,500 mcg/mL 10 units 3 mL → 1,667 mcg/mL 15 units 5 mL → 1,000 mcg/mL 25 units
More bacteriostatic water dilutes the same 250 mcg dose across more syringe units — the dose is unchanged; only the volume that carries it grows.

Reconstitution arithmetic worked through

Each block below is a self-contained conversion you can check by hand. They cover different vial sizes, water volumes, and doses so you can see how the formula behaves.

10 mg vial, 2 mL water, 250 mcg dose

Concentration: 10,000 ÷ 2 = 5,000 mcg/mL

Draw: 250 ÷ 5,000 = 0.05 mL

= 5 units — half the units of the same dose from a 5 mg vial at 2 mL

5 mg vial, 3 mL water, 250 mcg dose

Concentration: 5,000 ÷ 3 = 1,667 mcg/mL

Draw: 250 ÷ 1,667 = 0.15 mL

= 15 units — more water means a wider, easier-to-read draw

5 mg vial, 1 mL water, 250 mcg dose

Concentration: 5,000 ÷ 1 = 5,000 mcg/mL

Draw: 250 ÷ 5,000 = 0.05 mL

= 5 units — the tightest sensible draw on a U-100 syringe

10 mg vial, 5 mL water, 500 mcg dose

Concentration: 10,000 ÷ 5 = 2,000 mcg/mL

Draw: 500 ÷ 2,000 = 0.25 mL

= 25 units

Doses per vial — 5 mg vial at 250 mcg

Total: 5,000 mcg ÷ 250 mcg = 20 doses

A 5 mg vial yields 20 × 250 mcg portions regardless of water volume

Reverse check — 12 units back to mcg

Volume: 12 units ÷ 100 = 0.12 mL

At 2,500 mcg/mL: 0.12 × 2,500 = 300 mcg

Confirms the table row for 300 mcg

Why 10 units is not a fixed dose

At 5,000 mcg/mL: 10 units (0.10 mL) = 500 mcg

At 2,500 mcg/mL: 10 units (0.10 mL) = 250 mcg

Identical units, double the peptide — concentration is everything

Every-25-mcg rule at 2,500 mcg/mL

1 unit = 0.01 mL = 0.01 × 2,500 = 25 mcg

So 4 units = 100 mcg, 8 units = 200 mcg, and so on

Tiny draw warning — 100 mcg at 5,000 mcg/mL

Draw: 100 ÷ 5,000 = 0.02 mL

= 2 units — near the limit of reliable measurement; add more water for a wider draw

Skip the hand-arithmetic — enter your vial size, water volume and dose for an instant draw in mL and units.

Open the BPC-157 calculator →

Handling and storage notes

Bacteriostatic water is sterile water with roughly 0.9% benzyl alcohol, a preservative that lets a punctured multi-use vial resist bacterial growth — which is why it, not plain sterile water, is the standard diluent for a vial used over several weeks. Add water slowly down the vial wall rather than blasting the powder, swirl rather than shake, and expect a clear, colorless solution. Reconstituted vials are generally kept refrigerated at 2–8 °C and never frozen; discard if the solution turns cloudy or shows particles.

So, what is BPC-157?

BPC-157 is a synthetic 15-amino-acid peptide derived from a protein in human gastric juice, studied almost exclusively in preclinical rodent and cell models with no approved human dose. The reconstitution formula is straightforward: divide the total vial content in mcg by the bacteriostatic water added in mL to get concentration, divide your dose in mcg by that concentration for the draw in mL, then multiply by 100 for U-100 syringe units. To work through your own vial and dose instantly, use the BPC-157 dose calculator.

FAQs

What is BPC-157?
BPC-157 is a synthetic 15-amino-acid peptide derived from a protein in human gastric juice. It is a research-only compound with no FDA-approved human formulation and no clinically established dose; all published evidence is preclinical, drawn from rodent and in-vitro studies.
Is BPC-157 approved for human use?
No. BPC-157 is a research-only peptide with no FDA-approved human formulation and no clinically established dose. Published evidence is overwhelmingly preclinical — rodent and in-vitro studies of gastrointestinal, tendon, and wound-healing outcomes. This guide is a maths reference for unit conversion, not medical advice or an endorsement of use.
How much bacteriostatic water should I add?
There is no single correct amount — the water volume sets the concentration. For a 5 mg (5,000 mcg) vial, 1 mL gives 5,000 mcg/mL and 2 mL gives 2,500 mcg/mL. People often add 1–3 mL to keep per-dose draws in a readable 0.05–0.30 mL range on a U-100 syringe. The BPC-157 calculator shows the draw for any combination.
How do I convert an mcg dose into syringe units?
Divide the total vial content (mcg) by the water added (mL) to get concentration, divide your dose (mcg) by that concentration to get milliliters, then multiply by 100 for U-100 units. Example: 5,000 ÷ 2 = 2,500 mcg/mL; 250 ÷ 2,500 = 0.10 mL; 0.10 × 100 = 10 units.
Why does the same dose give different units?
Because units measure volume, not peptide mass. A 250 mcg dose is 10 units at 2,500 mcg/mL but only 5 units at 5,000 mcg/mL. The amount of peptide is identical; the concentration determines how much liquid carries it, and therefore how many units you draw.

Sources

BPC-157 evidence is preclinical (animal and in-vitro). The studies below are mechanistic and do not establish a human dose; this page uses them only to describe what the peptide is.

This guide does not constitute medical advice. BPC-157 is a preclinical research compound with no approved human dose; InjectBuddy is a mathematics tool for unit conversion only. Verify anything you do with a qualified prescriber.